Question

Teratogenicity

05 Mar 2024
Answer :
Word Count : 404

Teratogenicity refers to the ability of a substance to cause abnormalities in the development of an embryo or fetus, leading to birth defects. In the context of drugs regulatory affairs, teratogenicity is a critical aspect that regulatory agencies such as the FDA (Food and Drug Administration) in the United States or the EMA (European Medicines Agency) in Europe closely assess during the drug approval process.

Here's a breakdown of how teratogenicity is addressed in drugs regulatory affairs:

1. Preclinical Studies: Before a drug can be tested in humans, it undergoes extensive preclinical studies, which include animal studies. These studies aim to ________ ________ ___ ____ ___ ___ _______ _______ ________.
________ ________ ___ _______ _________ _________.
__________ _______ _____ _________ _________ ______.
__________ ____ ________ _________ _______ ___ _____ _____ ________ ______.
____ ____ __________ __________ ____.
___ __________ ____ ________ _______.
____ ______ ____ _________ ________ ________.
______ ______ ________ ________ ___ ______ _______ ___ _________ ____ ______.
___ _____ __________ ________ ___ _______ __________ ____.
__________ _________ _____ ______ ____ _________ ____ _______.
__________ ____ _________ _________ ____.
________ _________ _______ __________ ___ ______ _______ _________ _____.
_____ ________ ___ ____ __________ ______ ___ ____ ____ ______.
____ ___ __________ _______ _____ __________.
________ ________ ________ _____ _________ ______.
____ ____ ______ _____ ____.
_____ _____ _______ _______ __________ __________ __________ __________ __________ __________ _____.
_____ ____ _______ ________ ____ __________ __________ ________ ___ _________ ___ ____.
__________ _______ ___ ___ _____ __________ __________ ___ ________ ____ _________ _____.
_________ ___ ____ _____ ___ ______ ____ _________ ______ ______.
_____ ________ ________ __________ ______.
________ _______ ____ _________ _____ ____.
_________ _____ ______ _____ _______ ____ ____ ___ __________ ______ _____ ______.
___ ____ __________ __________ __________ __________.
_____ ______ __________ ____ ___ _____ _____ ______ _____ __________.
___ ____ ________ __________ __________ _________ _________ ___ _________ ____.
_______ _______ ____ ___ _______.
_____ ___ _____ ____ _________ _______.
_______ _________ _________ ______ ___ ___ ______ ___ _________ _________ __________.
_______ ________ ________ ___ ___.
_______ _____ __________ ________ _____ _____ _______ __________ _____ _____ __________.
_______ ___ ___ _____ __________ ______ _______ ____.
____ _______ __________ ___ _________ ____ _____ _______ ___ _______ ______ _________.
_________ ____ ________ ________ ______ _______ _____ ___.
_________ _____ ________ ___ ________ _________ _________ _____ ____ _______ _________.
_____ _________ _________ _________ _____ ___ _____ ____ ____ _________.
_______ ________ _____ ___ ___ ________ __________.
Get Full Answer on WhatsApp

IGNOU NEWS
Assignment Submission Last Date Extended Till 30 June 2026 Click Here★★★IGNOU June 2026 TEE Date Sheet Released Click Here★★★
Top
📞
Call Support Instant phone assistance Teratogenicity
→
🟢
WhatsApp Chat Fast live messaging
→
Email Us Business enquiries & support
→